We are live on ! Find out more
Commonwealth Equity Services

Commonwealth Equity Services Portfolio holdings

AUM $71.6B
1-Year Est. Return 21.08%
This Fund
S&P 500
This Quarter Est. Return
+6.54%
1 Year Est. Return
+21.08%
3 Year Est. Return
+64.42%
5 Year Est. Return
+73.55%
10 Year Est. Return
+239.11%
AUM
$49.2B
AUM Growth
+$49.1B
Cap. Flow
-$331M
Cap. Flow %
-0.67%
Top 10 Hldgs %
18.57%
Holding
3,990
New
215
Increased
1,990
Reduced
1,469
Closed
159

Sector Composition

Rank Sector Weight
1 Technology 11.77%
2 Financials 5.19%
3 Healthcare 4.56%
4 Consumer Discretionary 4.48%
5 Industrials 3.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SGMA
3701
DELISTED
Sigmatron International
SGMA
$35K ﹤0.01%
10,711
ANIX icon
3702
Anixa Biosciences
ANIX
$126M
$34K ﹤0.01%
+10,571
New +$40.7K
CTXR icon
3703
Citius Pharmaceuticals
CTXR
$14.3M
$34K ﹤0.01%
1,130
TDAY
3704
USA Today Co
TDAY
$1.23B
$34K ﹤0.01%
+15,013
New +$29.9K
JOB icon
3705
GEE Group
JOB
$23.4M
$34K ﹤0.01%
66,551
CVM icon
3706
CEL-SCI Corp
CVM
$20.6M
$33K ﹤0.01%
459
DOUG icon
3707
Douglas Elliman
DOUG
$155M
$33K ﹤0.01%
14,993
-34
-0.2% -$93
DBVT
3708
DBV Technologies
DBVT
$807M
$32K ﹤0.01%
1,670
+100
+6% +$1.81K
EMX
3709
DELISTED
EMX Royalty
EMX
$32K ﹤0.01%
16,745
+371
+2% +$722
YCBD.PRA
3710
DELISTED
cbdMD, Inc. 8.0% Series A Cumulative Convertible Preferred Stock
YCBD.PRA
$32K ﹤0.01%
+10,000
New +$31.4K
SEEL
3711
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
$32K ﹤0.01%
7
-1
-13% -$3.47K
BIRD icon
3712
Smartbird Inc
BIRD
$21.7M
$31K ﹤0.01%
1,247
-54
-4% -$1.35K
SNDL icon
3713
Sundial Growers
SNDL
$325M
$31K ﹤0.01%
22,631
-598
-3% -$908
BNGO icon
3714
Bionano Genomics
BNGO
$12.7M
$30K ﹤0.01%
81
+10
+14% +$4.51K
CAN
3715
Canaan Creative
CAN
$176M
$30K ﹤0.01%
14,190
+400
+3% +$969
DMRA
3716
Damora Therapeutics, Inc. Ordinary Shares
DMRA
$1.77B
$30K ﹤0.01%
478
+71
+17% +$3.87K
ADAP
3717
DELISTED
Adaptimmune Therapeutics
ADAP
$29K ﹤0.01%
+31,875
New +$38K
GEVO icon
3718
Gevo
GEVO
$397M
$29K ﹤0.01%
19,336
+1,475
+8% +$1.91K
BDSX icon
3719
Biodesix
BDSX
$228M
$28K ﹤0.01%
1,153
+624
+118% +$18.7K
CATX icon
3720
Perspective Therapeutics
CATX
$332M
$28K ﹤0.01%
4,228
-100
-2% -$607
DPRO
3721
Draganfly
DPRO
$156M
$28K ﹤0.01%
870
GOEV
3722
DELISTED
Canoo Inc. Class A Common Stock
GOEV
$28K ﹤0.01%
129
+11
+9% +$3.14K
TGB
3723
Trekor Metals
TGB
$2.56B
$27K ﹤0.01%
18,695
+200
+1% +$299
WHLRP
3724
Wheeler Real Estate Investment Trust Preferred Stock
WHLRP
$8.73M
$27K ﹤0.01%
17,060
RGLS
3725
DELISTED
Regulus Therapeutics
RGLS
$26K ﹤0.01%
17,500

Similar funds

Commonwealth Equity Services's Q2 2023 Portfolio in Review

As of Q2 2023, Commonwealth Equity Services held 3,990 positions worth $49.2B, up 103,090% from $47.6M the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Commonwealth Equity Services's Q2 2023 filing shows 215 new, 1,990 increased, 1,469 reduced and 159 closed positions. Its largest new stake was State Street SPDR Portfolio Mortgage Backed Bond ETF: 356,887 shares worth $7.82M. The largest sale was Chevron, an estimated $1.65B.

By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 10% a quarter earlier, followed by Financials and Healthcare.

  • Commonwealth Equity Services's largest Q2 2023 buy was State Street SPDR Portfolio Mortgage Backed Bond ETF: 356,887 shares worth $7.82M.
  • Commonwealth Equity Services added most to Invesco QQQ Trust in Q2 2023, an estimated $65.7M increase.
  • Commonwealth Equity Services's biggest Q2 2023 reduction was Chevron, cutting an estimated $1.65B.
  • Commonwealth Equity Services fully exited AdvisorShares Dorsey Wright Alpha Equal Weight ETF in Q2 2023, selling an estimated $28.5K.
  • Commonwealth Equity Services's ten largest holdings make up 19% of its $49.2B portfolio in Q2 2023.
  • Commonwealth Equity Services opened 215 new positions and closed 159 in Q2 2023.
  • Commonwealth Equity Services's portfolio value rose 103,090% quarter-over-quarter to $49.2B.

Based on Commonwealth Equity Services's 13F filing for Q2 2023, filed 10 Aug 2023.